Startups
PharmCADD is a company designed to accelerate drug discovery meanwhile performing a design without building or maintaining the infrastructure associated with high-performance computational resources. The platform for both the design and discovery in the PharmCADD is composed of the state-of-the art technology: AI (Artificial intelligence), Molecular Dynamics (MD), Quantum Calculation (QC), and Network theory.
AI, which is data-derived technology emerges as a new trend which could potentially be very revolutionary in our modern world. It enables customers to accelerate the search for a certain or specific drug candidate in the vast existence of chemical space.
On the other hand, MD and quantum calculation, physics-based technology, enables the customers to characterize potential drug candidates more precisely. The effective combination of the data-derived and physics-based technologies leads to more accurate and speedier drug discovery.
AI, which is data-derived technology emerges as a new trend which could potentially be very revolutionary in our modern world. It enables customers to accelerate the search for a certain or specific drug candidate in the vast existence of chemical space.
On the other hand, MD and quantum calculation, physics-based technology, enables the customers to characterize potential drug candidates more precisely. The effective combination of the data-derived and physics-based technologies leads to more accurate and speedier drug discovery.
Overview
Location
South Korea, Busan
Employees
11-50
Total raised
$16M
Founded date
2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 19, 2021 | PharmCADD Raised USD 16m in Series B Funding | PharmCADD, a Korean Artificial Intelligence (AI) and Physics-based drug discovery company announced that it has finished USD 16 million series B funding on March 31, 2021. This funding round was led by Strategic Investors: Huons, Samyang Ho... |
| Apr 19, 2021 | PharmCADD Raises USD16M in Series B Funding | PharmCADD, a Busan, South Korea-based Artificial Intelligence (AI) and Physics-based drug discovery company, raised USD 16m in Series B funding. The round, which brought total funding raised to date to USD 22m, was led by strategic investor... |
Reviews 0
FAQ about PharmCADD
When was PharmCADD founded?
PharmCADD was founded in 2019.
How much funding has PharmCADD raised?
PharmCADD has raised $16M in total across 1 funding round.
What has the press written about PharmCADD?
Parsers VC has collected 3 articles mentioning PharmCADD, among them “PharmCADD Raised USD 16m in Series B Funding” (Apr 19, 2021) and “PharmCADD Raises USD16M in Series B Funding” (Apr 19, 2021).
Is PharmCADD still active?
Yes, PharmCADD is active; its latest activity on Parsers VC dates from Apr 19, 2021.